Category Archives: Pradaxa

Featured Stories

New York Man Claims Biomet Metal-on-Metal Hip Implant Caused Pain, Disability

A New York man claims his metal-on-metal hip implant was defective and required replacement within a year of receiving it. This has left him facing a lifetime of pain, disability, and rising medical costs.

Read More

FDA Gives 7 Companies Go Ahead To Market Generic Plavix

The U.S. Food & Drug Administration (FDA) just gave seven companies the go-ahead to market generic Plavix. Plavix is a blood thinner prescribed for the prevention of blood clots, heart attacks, and which has been linked to serious side effects such as the heart attacks and strokes it is supposed to ...

Read More

System for Tracking Prescription Drug Side Effects Flawed

Study Finds System for Tracking Prescription Drug Side Effects Flawed

System for keeping track of dangerous side effects of prescription drugs is flawed because drug makers are submitting incomplete information about problems to the FDA.

Read More

Decision on Pradaxa Bleeding Lawsuit Multidistrict Litigation Expected Soon

Victims of alleged Pradaxa injuries are awaiting word on whether their lawsuits will be consolidated in a multidistrict litigation. According to a report from The Madison Record, so far just over two dozen Pradaxa bleeding lawsuits have been filed in federal courts throughout the U.S.

Read More

FDA Warning for Bone Graft Products in Patients Under 18

FDA Safety Warning for Bone Graft Products in Patients Under 18

FDA issued safety alerts to patients, parents & guardians, bone graft devices w/recombinant proteins or synthetic peptides not to be the first treatment for 18 & under.

Read More

Study Finds SSRI Antidepressant Side Effects Outweigh Their Benefits

A new study is raising more concerns about the safety of commonly used antidepressants, including selective serotonin reuptake (SSRI) inhibitor antidepressants. Investigators who conducted the study, which is published in the journal Frontiers in Psychology, posit that increased knowledge of the negative effects of SSRIs and other antidepressants could reduce ...

Read More

Failing DePuy ASR Hip Implants Sending Hundreds of Australians Back to the OR

Roughly 1,000 people in Australia have had to undergo revision surgeries because of failed DePuy ASR hip implants. According to TheAge.com, DePuy Orthopaedics has heard from more than 4,000 people in Australia and New Zealand seeking help with the recalled metal-on-metal hip replacement devices.

Read More

Tentative Ohio Fracking Regulations Criticized as too Lax

Lawmakers in Ohio have tentatively passed new regulations governing hydraulic fracturing (fracking) drilling but they’ve immediately been criticized for being too favorable to the natural gas and oil industries.

Read More

EMA Seeks Stronger Pradaxa Guidance for Bleeding Side Effects

Regulators in Europe have again asked Boehringer Ingelheim, the manufacturer of the blood thinner Pradaxa, to update the drug’s label with additional information regarding Pradaxa bleeding side effects. According to the European Medicines Agency (EMA), the new guidance should include more specific information on when Pradaxa must not be used, ...

Read More

Lawsuits over DePuy ASR Metal-on-Metal Hip Implants Continue to Mount

DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be hit with lawsuits over recalled metal-on-metal DePuy ASR hip implants. Just yesterday, the national law firm of Parker Waichman LLP announced it had filed yet another DePuy ASR hip implant lawsuit, this time on behalf of a Virginia resident ...

Read More

Xarelto Plaintiffs Hope for Outcome Similar to Pradaxa Settlement

Xarelto Plaintiffs Hope for Similar Pradaxa Settlement

The current multidistrict litigation (MDL) comprised of more than 7,000 Xarelto (rivoxaban) lawsuits filed against the Johnson & Johnson subsidiary, Janssen Pharmaceuticals, and Bayer AG is being overseen by the Honorable Judge Eldon E. Fallon in the Eastern District of … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged , , , , , |

Pradaxa Linked to Brain Bleeds

Pradaxa Linked to Brain Bleeds

Researchers report that they have found a possible link between the anticoagulant drug Pradaxa and intracerebral hemorrhage (brain bleeding). When a blood vessel wall or vein is damaged, the vessel can leak blood into tissues, causing a hematoma, a swelling … Continue reading

Posted in Health Concerns, Pharmaceuticals, Pradaxa | Tagged , , , , , , , , , , , , , , , , |

Pradaxa Settlement Does Not Bar New Lawsuits

Despite a 2014 mass settlement, patients who have suffered bleeding injuries after taking Pradaxa may still qualify to bring a Pradaxa lawsuit. Pradaxa is one of the newer class of blood-thinning medication prescribed to help prevent blood clots and stroke … Continue reading

Posted in Defective Products, Health Concerns, Pharmaceuticals, Pradaxa |

Anticoagulant Xarelto Lawsuit Cases Keep Drawing Attention

Lawsuits seeking damages from the makers of Xarelto, Bayer AG and Janssen Pharmaceuticals (a subdivision of Johnson & Johnson), have surpassed 3,000 in number with many plaintiffs alleging they suffered similar harm resulting from taking the drug, reports the Digital … Continue reading

Posted in Health Concerns, Legal News, Pharmaceuticals, Pradaxa |

Blood Thinner Xarelto Lawsuit Continues to Draw Attention

Regarding the multitude of cases brought against the manufacturers of the anticoagulant drug, Xarelto, Bayer AG, Janssen Pharmaceuticals, a division of Johnson & Johnson, have surpassed 3,000 cases and many allege similar harm as a result of using the drug, … Continue reading

Posted in Health Concerns, Pharmaceuticals, Pradaxa |

Xarelto Studies Question Drugs Benefits and Risks and Reveal Eye Bleeding in Some Cases

A number of study results are prompting questions over Xarelto (rivaroxaban) and other new-generation anticoagulant drugs (blood thinners). Bayer Healthcare and Janssen Pharmaceuticals, a division of the Johnson & Johnson Corporation, manufacture Xarelto. Xarelto received U.S. Food and Drug Administration … Continue reading

Posted in Pharmaceuticals, Pradaxa |

Motion to Consolidate Xarelto Bleeding Side Effects Cases in Multidistrict Litigation

Plaintiffs who allege they were injured by the blood thinner Xarelto have filed a motion to have their cases consolidated as part of a multidistrict litigation (MDL). At least 21 actions pending in 10 judicial districts make similar allegations against … Continue reading

Posted in Defective Products, Pharmaceuticals, Pradaxa |

Pradaxa Maker Reaches $650 Million Settlement in State and Federal Litigation

Drug maker Boehringer Ingelheim announced today that it had reached a $650 million settlement of state and federal cases involving the blood thinner Pradaxa (dabigatran). Though the company says it “stands resolutely behind” Pradaxa and believes the claims in the … Continue reading

Posted in Health Concerns, Legal News, Pharmaceuticals, Pradaxa |

FDA Study: Pradaxa Has Higher Risk for Gastrointestinal Bleeding than Warfarin

A study recently completed by the Food and Drug Administration (FDA) found an increased risk of major gastrointestinal bleeding with the blood thinner Pradaxa (dabigatran) compared to warfarin. Pradaxa and warfarin (Coumadin) are prescribed to reduce the risk of stroke … Continue reading

Posted in Health Concerns, Pharmaceuticals, Pradaxa |

Xarelto Caused Internal Bleeding, Lawsuit Claims

xarelto-bleeding-lawsuits

A Kentucky woman has filed suit against Johnson & Johnson and Bayer AG in Pennsylvania court, alleging that she suffered severe internal bleeding from the use of the blood-thinner Xarelto (rivaroxaban). Virginia Stuntebeck’s lawsuit says the drug should not be … Continue reading

Posted in Health Concerns, Legal News, Pharmaceuticals, Pradaxa |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.